--- a
+++ b/clusters/3009knumclusters/clust_198.txt
@@ -0,0 +1,669 @@
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding women
+Woman who are pregnant or breastfeeding
+Pregnant or breastfeeding.
+Females who are pregnant or breastfeeding
+Currently pregnant or breastfeeding
+Pregnant or breastfeeding
+Patients who are pregnant or breastfeeding are excluded from the study
+Women who are breastfeeding or pregnant as evidenced by a positive pregnancy test within 14 days of first dose.
+18. Pregnancy or breastfeeding women.
+Women who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding (unless the patient is willing to interrupt breastfeeding during study treatment administration and then resume 6 months after study discontinuation); women of childbearing potential must not consider getting pregnant during the study
+Women must not be breastfeeding.
+Patient is pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding, or intending to become pregnant during the study
+Pregnant or breastfeeding.
+Pregnant or breastfeeding women
+Patients may not be pregnant or breastfeeding
+Women must not be breastfeeding
+Women must not be breastfeeding
+Pregnant or breastfeeding females
+Pregnant or breastfeeding women
+Patient is pregnant or breastfeeding
+Females who are pregnant (positive urine test) or breastfeeding
+Pregnant female patients; breastfeeding female patients; male patients with partners currently pregnant.
+Is a female subject who is pregnant or breastfeeding.
+Pregnant or breastfeeding
+Pregnant or breastfeeding women.
+Pregnant women or women who are breastfeeding
+Pregnant or breastfeeding.
+Pregnant or breastfeeding
+Females who are pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+Pregnant or breastfeeding female patients
+Pregnant or breastfeeding women will be excluded from participation in this trial
+Are pregnant or breastfeeding.
+Is not pregnant or breastfeeding
+Females who are pregnant or breastfeeding
+Women must not be pregnant or breastfeeding
+Pregnant or breastfeeding females.
+Female subjects of childbearing potential must not be pregnant or breastfeeding
+Pregnant or breastfeeding female.
+Patients must not be pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Females only: pregnant or breastfeeding
+Pregnant or breastfeeding
+If female, is pregnant, breastfeeding, or planning to become pregnant.
+Pregnant or breastfeeding women.
+Pregnant or breastfeeding.
+Currently pregnant or breastfeeding
+Pregnant or breastfeeding women, or intending to become pregnant during the study
+Subject is pregnant or breastfeeding.
+Breastfeeding or pregnant.
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding, or intending to become pregnant during the study
+If female, is pregnant, breastfeeding, or planning to become pregnant.
+Female subject who is pregnant or breastfeeding.
+If female, subject is pregnant and/or breastfeeding.
+Breastfeeding
+Women who are pregnant or breastfeeding
+Female patients may not be pregnant or breastfeeding
+Subjects that are pregnant or breastfeeding an infant.
+Pregnant or breastfeeding
+Pregnant women and women who are breastfeeding are excluded from this study
+Pregnant or breastfeeding
+Women who are breastfeeding and who are unwilling to stop breastfeeding prior to study entry
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Patient must not be pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Females must not be breastfeeding
+Women must not be breastfeeding.
+Pregnant or breastfeeding females.
+Women must not be breastfeeding
+Women who are breastfeeding
+Females who are pregnant or breastfeeding
+Currently pregnant or breastfeeding
+Women of childbearing potential who are pregnant or breastfeeding
+Patients that are pregnant or breastfeeding
+Women who are breastfeeding.
+Women who are pregnant or breastfeeding
+Women must not be breastfeeding.
+Female patients who are pregnant or breastfeeding
+Pregnant or breastfeeding, or intending to become pregnant during the study or within 140 days after the last dose of BTRC4017A
+Pregnant or breastfeeding.
+Females who are pregnant or breastfeeding
+Participants who are women must not be breastfeeding
+Pregnant or breastfeeding
+Women must not be breastfeeding.
+Pregnant or breastfeeding.
+Inability or refusal to practice effective contraception during therapy or the presence of pregnancy or active breastfeeding; pregnant or breastfeeding women will be excluded from participation in this trial
+Pregnant women and women who are breastfeeding are excluded from this study
+Women who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding.
+Pregnancy, breastfeeding, or intention of becoming pregnant during the study
+Pregnant or breastfeeding
+Female participants who are pregnant or breastfeeding are excluded.
+Females who are pregnant or breastfeeding.
+Pregnant or breastfeeding female patients
+Pregnant or breastfeeding.
+Women must not be pregnant (as above) or breastfeeding
+Pregnant or breastfeeding, or intending to become pregnant during the study
+Pregnant or breastfeeding
+Women must not be pregnant (as above) or breastfeeding
+Female patients who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding or planning to become pregnant within 90 days after their last anticipated dose of BCV
+The participant is pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Women must not be breastfeeding.
+Pregnant or breastfeeding females
+Patients who are pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+Are females who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding
+Women must not be breastfeeding.
+Females must not be breastfeeding
+Pregnant or breastfeeding
+Patient is pregnant or breastfeeding
+Women must not be breastfeeding.
+WOCBP who are pregnant or breastfeeding.
+Women who are breastfeeding
+Pregnant, breastfeeding, or plan to become pregnant during the study duration
+HEALTHY SUBJECT: Not pregnant or breastfeeding
+Female subjects who are pregnant, are planning on becoming pregnant, or are currently breastfeeding.
+Women must not be breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or actively breastfeeding women
+Women who are pregnant or breastfeeding
+Subject is pregnant or breastfeeding.
+Pregnant and/or breastfeeding
+Women must not be breastfeeding
+DONOR: WOCBP: Pregnant or =< 6 months breastfeeding
+Female patients who are pregnant or breastfeeding; breastfeeding should be discontinued
+Pregnant or breastfeeding women are excluded from this study
+Women must not be breastfeeding
+CRITERIA FOR SCREENING: Pregnant or breastfeeding women
+Women must not be breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding women;
+Pregnant or breastfeeding
+Women must not be breastfeeding
+Pregnant and/or breastfeeding
+DONOR: Pregnant and/or breastfeeding
+Pregnant or breastfeeding women
+Subjects who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding
+Pregnant women and breastfeeding mothers are excluded
+Females who are pregnant or are currently breastfeeding
+Patients who are pregnant or breastfeeding
+Pregnant or breastfeeding females
+Breastfeeding females
+Women must not be breastfeeding
+Patients who are pregnant, are lactation, or breastfeeding
+Pregnant or breastfeeding females
+Breastfeeding or pregnant
+Pregnant or breastfeeding women
+Women who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnancy, breastfeeding or possibility of becoming pregnant during the study.
+Is pregnant or breastfeeding
+Women who are breastfeeding
+Women of childbearing potential who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Females who are pregnant or breastfeeding.
+Women must not be breastfeeding
+Women who are of pregnant or breastfeeding
+The patient is pregnant or is breastfeeding.
+Women who are pregnant or breastfeeding; women who agree to stop breastfeeding would be eligible
+Patients who are pregnant or breastfeeding will be excluded from the study
+Subjects who are pregnant or breastfeeding are excluded
+Pregnant or breastfeeding (female only)
+Pregnant and/or breastfeeding
+DONOR: Pregnant and/or breastfeeding
+Females must not be breastfeeding
+Pregnant or breastfeeding
+Pregnant and breastfeeding women are excluded.
+Pregnant or breastfeeding
+Is pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Pregnant or breastfeeding females.
+Women who are pregnant or breastfeeding
+Female subjects who are breastfeeding, pregnant, or plan to become pregnant during the study or within 3 months following the last dose of investigational product
+Pregnant or breastfeeding
+Women who are pregnant, or who are currently breastfeeding
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding women.
+Women must not be breastfeeding
+Breastfeeding women.
+Women who are pregnant or breastfeeding
+DONOR: Pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding women are excluded from this study
+Women who are pregnant or breastfeeding are excluded from the study
+Pregnant or breastfeeding participants
+Female subjects who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Women must not be breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+ADDITIONAL CRITERIA FOR STUDY CONTINUATION: Pregnant or breastfeeding
+Pregnant or breastfeeding women are excluded from this study
+Patient is pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding.
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+PART 1: Pregnant or breastfeeding
+PART 2: Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Women must not be breastfeeding
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding women are excluded from this study
+Patients who are pregnant or breastfeeding
+The subject is pregnant or breastfeeding
+Pregnant or breastfeeding women are excluded from this study; breastfeeding should be discontinued
+Females who are pregnant or breastfeeding
+Women who are breastfeeding
+Pregnant women are excluded from this study; breastfeeding should also be avoided
+The subject is pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Pregnant and breastfeeding women are excluded from this study
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+Patient must not be pregnant or breastfeeding
+Pregnant women are excluded from this study; breastfeeding should also be avoided
+Females who are pregnant or are currently breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Are pregnant or breastfeeding.
+Patients who are pregnant or breastfeeding are excluded from the study
+Female patients who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding female
+Pregnant or breastfeeding woman.
+Pregnant or breastfeeding
+Participant is pregnant or is a breastfeeding female
+Women must not be breastfeeding
+Patients who are currently pregnant or breastfeeding.
+Are pregnant or breastfeeding
+Female patients who are breastfeeding.
+Females must not be pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Pregnant or breastfeeding women.
+Pregnant or breastfeeding women
+Pregnant and/or breastfeeding
+Females must not be breastfeeding
+WOCBP: Pregnant or breastfeeding
+Pregnant or is breastfeeding
+Pregnant or breastfeeding
+Patients who are pregnant or breastfeeding.
+Patients who are pregnant or breastfeeding
+Pregnant or breastfeeding female patients.
+Pregnant or breastfeeding
+Female only: pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding females.
+Pregnant or breastfeeding females.
+Pregnant or breastfeeding, or planning to become pregnant within 6 months after the end of treatment
+Pregnant or breastfeeding females
+Pregnant women are excluded from this study; breastfeeding should also be avoided
+Pregnant or breastfeeding
+Are female and pregnant or breastfeeding.
+Pregnant or breastfeeding female.
+Participants who are pregnant or breastfeeding
+Women currently pregnant or breastfeeding
+Female patient who is breastfeeding.
+Women must not be breastfeeding
+Women who are pregnant or breastfeeding
+TUMOR BIOPSY SEQUENCING: Women who are pregnant or breastfeeding
+TREATMENT: Women who are pregnant or breastfeeding
+Women must not be pregnant (as above) or breastfeeding
+Pregnant or breastfeeding patients are not eligible
+Women who are pregnant or breastfeeding
+Females must not be breastfeeding
+Not breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Female participants must not be breastfeeding
+The subject is pregnant or breastfeeding
+Female patients who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Female subject who is pregnant or breastfeeding
+Breastfeeding patients are ineligible
+Pregnant or breastfeeding
+Female patient who is pregnant or breastfeeding
+Women who are breastfeeding
+Women must not be pregnant or breastfeeding; breastfeeding must be discontinued or the subject is not eligible for the study
+PHASE II: Women must not be pregnant or breastfeeding; breastfeeding must be discontinued or the subject is not eligible for the study
+Patient must not be pregnant and/or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Women who are breastfeeding
+The subject is pregnant or breastfeeding.
+Subjects who are pregnant or breastfeeding.
+Currently pregnant or breastfeeding
+Females who are pregnant or breastfeeding; women of childbearing potential must not be considering getting pregnant during the study
+Females who are pregnant, unable to comply with birth control use to avoid becoming pregnant or breastfeeding
+Patients who are pregnant or breastfeeding.
+Females who are pregnant or breastfeeding.
+Pregnant or breastfeeding women.
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Breastfeeding or pregnant.
+Pregnant or breastfeeding
+Breastfeeding
+Pregnant and breastfeeding women are excluded from this study
+Pregnant or breastfeeding women.
+Participants who are breastfeeding, or intending to become pregnant during the study
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Females who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Is pregnant or breastfeeding.
+Be pregnant, planning a pregnancy, or breastfeeding
+Pregnant or breastfeeding women.
+Pregnant or breastfeeding patients;
+Pregnant or breastfeeding
+Pregnant or breastfeeding.
+Females who are pregnant or breastfeeding
+Pregnant or breastfeeding woman or female who intends to become pregnant during the participation in the study.
+Women must not be breastfeeding
+are pregnant or breastfeeding
+Breastfeeding or pregnant
+Females who are pregnant or breastfeeding as well as all females of childbearing potential who:
+Breastfeeding women.
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Are pregnant or breastfeeding.
+Women who are breastfeeding
+Females who are pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Women who are pregnant or breastfeeding
+Subject is pregnant or breastfeeding or intends to get pregnant within 28 days of enrolling into the study.
+Female patients who are pregnant or breastfeeding
+Subject if female, is pregnant or breastfeeding
+Women must not be breastfeeding.
+Women who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding.
+Women must not be breastfeeding
+Females who are pregnant or breastfeeding.
+Women must not be breastfeeding at the time of study registration
+Patients who are pregnant or breastfeeding
+Is pregnant, breastfeeding, or planning a pregnancy
+Women who are pregnant or breastfeeding
+Current breastfeeding (females only)
+Breastfeeding and pregnant.
+Women must not be breastfeeding
+Females who are pregnant or breastfeeding.
+Breastfeeding or pregnant
+Women must not be breastfeeding
+WOCBP who are pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Women who are breastfeeding.
+Breastfeeding or pregnant
+Pregnant or breastfeeding
+Pregnant or breastfeeding women
+Women who are pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+Women must not be pregnant or breastfeeding
+Pregnant or breastfeeding females
+Patient is pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Female subjects that are pregnant or breastfeeding are not eligible
+Pregnant or breastfeeding
+Be pregnant or breastfeeding.
+Breastfeeding
+Women who are breastfeeding or pregnant
+Pregnant or breastfeeding.
+Are pregnant or breastfeeding
+A participant who is pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Patient is breastfeeding.
+Pregnant or patients who are breastfeeding
+Women who are pregnant or breastfeeding
+Women who are breastfeeding or pregnant
+Women must not be breastfeeding.
+Women who are pregnant or breastfeeding
+Is pregnant or breastfeeding
+Breastfeeding women, pregnant women
+Participant is pregnant or breastfeeding
+PART B: Pregnant or breastfeeding women
+Pregnant and/or breastfeeding
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding.
+The patient is pregnant or breastfeeding
+Pregnant women or women who are breastfeeding are excluded from this study
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Females who are pregnant or are currently breastfeeding
+Pregnant or breastfeeding
+Patient must not be pregnant and/or breastfeeding
+Be a woman who is pregnant or breastfeeding
+Must not be pregnant or breastfeeding.
+Women must NOT be pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+The participant is pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding patients
+Women who are pregnant or breastfeeding
+Female patients who are pregnant or currently breastfeeding
+Females must not be breastfeeding
+Pregnant (positive ?-HCG) or breastfeeding.
+Pregnant or breastfeeding; breastfeeding may not resume for 14 days after the last dose of pazopanib
+Patients who are pregnant or breastfeeding
+Pregnant, or actively breastfeeding females.
+Female patients who are breastfeeding or pregnant
+The subject is pregnant or breastfeeding
+Patient is pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding females
+Pregnant or breastfeeding
+EXPANSION COHORT ONLY: Pregnant or breastfeeding
+Pregnant or breastfeeding women
+Females who are pregnant or breastfeeding
+Female patients who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Patient is pregnant or breastfeeding
+Women who are breastfeeding
+Women who are pregnant or breastfeeding
+Breastfeeding mothers
+Women who are breastfeeding
+Pregnant or breastfeeding patients
+Pregnant or breastfeeding women
+Pregnant women or females who are breastfeeding
+Currently pregnant or breastfeeding.
+Women who are breastfeeding
+Breastfeeding or pregnant.
+Women who are pregnant or breastfeeding
+Women who are breastfeeding
+Women who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding
+Women must not be breastfeeding
+Women who are pregnant or breastfeeding
+Women who are breastfeeding
+The participant is pregnant, breastfeeding, or planning to become pregnant or father a child
+Breastfeeding or pregnant
+Female subjects that are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding
+Are pregnant or breastfeeding
+Women who are pregnant (including positive pregnancy test at enrollment or prior to study drug administration) or breastfeeding
+Pregnant women and women who are breastfeeding are excluded from this study
+Females who are pregnant or breastfeeding
+16. Women who are pregnant or breastfeeding.
+Women who are pregnant or breastfeeding.
+Women that are pregnant or breastfeeding
+Subject is currently pregnant or breastfeeding, or is planning to become pregnant during the study
+Women must not be breastfeeding
+Pregnant or breastfeeding females
+Pregnant or breastfeeding women
+Females who are pregnant or breastfeeding.
+Women must not be breastfeeding
+Are pregnant or breastfeeding.
+Subject is pregnant or breastfeeding
+Pregnant, breastfeeding, or planning to become pregnant during the study;
+Women who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding.
+Not breastfeeding
+Women must not be breastfeeding
+(Female only) not breastfeeding
+(Female only) is not breastfeeding
+Women must not be breastfeeding.
+Participants who are pregnant or breastfeeding
+Pregnant or breastfeeding women
+Patients may not be pregnant or breastfeeding
+Women who are breastfeeding or pregnant
+The subject is pregnant or breastfeeding.
+Pregnant or breastfeeding women are excluded from this study; breastfeeding should be discontinued
+Women of childbearing potential who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Is pregnant, breastfeeding, or planning a pregnancy
+Women who are pregnant or breastfeeding.
+Pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Pregnant or breastfeeding.
+Women who are breastfeeding
+Pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Is the subject breastfeeding?
+Pregnant or breastfeeding
+Females of childbearing potential who are not pregnant or breastfeeding
+Patients who are pregnant or breastfeeding.
+The subject is pregnant or breastfeeding
+Female subjects who are pregnant or breastfeeding.
+Pregnant or breastfeeding women.
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Pregnant or breastfeeding women
+Females must not be breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding females
+The subject is pregnant or breastfeeding
+Pregnant or breastfeeding, or intending to become pregnant during the study
+Females who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Women must not be breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding females
+Be pregnant or breastfeeding
+Recipient must not be pregnant and/or breastfeeding.
+Pregnant or breastfeeding females
+Females who are pregnant or are breastfeeding.
+The subject is pregnant or breastfeeding
+Breastfeeding or pregnant females
+Female subjects who are pregnant or breastfeeding.
+Pregnant (positive total HCG) or breastfeeding
+Pregnant or breastfeeding (women)
+Women who are breastfeeding
+Pregnant and/or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding females
+Female subjects who are pregnant, or breastfeeding, or planning to become pregnant. Male subjects who plan to father a child while enrolled in this protocol.
+Pregnant, breastfeeding or considering becoming pregnant within 6 months following the last dose of investigational product;
+Subject is pregnant or breastfeeding.
+Pregnant or breastfeeding
+Pregnant and/or breastfeeding
+As per self-report participants who are pregnant or who are breastfeeding
+Pregnant or breastfeeding
+Pregnant and breastfeeding women are excluded from this study
+Not pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant and breastfeeding women are not eligible for thyroidectomy and so are excluded from this study
+Pregnant or breastfeeding
+For women: breastfeeding, pregnancy, or plan to become pregnant within 6 months
+Patients who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding are ineligible
+Female patients who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Females who are pregnant or are currently breastfeeding
+Pregnant or breastfeeding women; positive pregnancy test within 7 days of starting treatment
+Females who are pregnant or breastfeeding
+Females who are pregnant or breastfeeding;
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding
+Patient must not be pregnant and/or breastfeeding
+Patient must not be pregnant and/or breastfeeding
+Female subjects who are pregnant or breastfeeding
+Female subjects who are pregnant or breastfeeding
+Is pregnant or breastfeeding
+Female who is pregnant or breastfeeding
+Patients who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Participants who are breastfeeding are excluded
+Women who are pregnant (positive serum or urine ?HCG) or breastfeeding
+They are not breastfeeding;
+Pregnant or intention to get pregnant, or breastfeeding; pregnant women are excluded from this study; women who are breastfeeding will be excluded
+Currently breastfeeding.
+Pregnant and/or breastfeeding
+Breastfeeding women
+Pregnant or breastfeeding
+Women who are breastfeeding are not eligible for this study.
+Women who are breastfeeding, pregnant, or planning pregnancy within the next year
+Pregnant or breastfeeding
+Pregnant, contemplating getting pregnant, or breastfeeding
+For women, current pregnancy or breastfeeding or plan to become pregnant during the next 2 months.
+Pregnant or breastfeeding.
+Current breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Breastfeeding
+Is pregnant, intends to become pregnant during study, or is breastfeeding
+Pregnant and/or breastfeeding
+Breastfeeding women
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+No breastfeeding
+Pregnant, contemplating getting pregnant, or breastfeeding
+Pregnant or breastfeeding
+men and non-pregnant, non-breastfeeding women
+Pregnant or breastfeeding.
+Women who are breastfeeding
+Women must not be breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding women
+Pregnant or breastfeeding
+Breastfeeding
+Pregnant or breastfeeding
+Not pregnant and/or breastfeeding
+Pregnant or breastfeeding.
+Patient must NOT be breastfeeding.
+Female patients who are pregnant or breastfeeding
+Pregnant or breastfeeding women
+Not pregnant and/or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant and breastfeeding patients
+Women who are pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Participants who are breastfeeding are excluded
+Women must not be pregnant nor breastfeeding
+Women who are breastfeeding
+Pregnant or breastfeeding
+Pregnant or breastfeeding
+Pregnant and breastfeeding patients
+Patient who is pregnant and/or breastfeeding
+Pregnant or breastfeeding
+Pregnant and/or breastfeeding
+Patient must not be pregnant or breastfeeding
+Patient must not be pregnant or breastfeeding
+Patient must not be pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding females.
+Is pregnant or breastfeeding
+Pregnant and/or breastfeeding women.
+Female patients who are pregnant or actively breastfeeding
+Pregnant or breastfeeding
+Not pregnant, not breastfeeding
+You are pregnant or breastfeeding
+Pregnant or breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant or breastfeeding at time of consent
+NORMAL VOLUNTEERS: If female, pregnant or breastfeeding at time of consent
+Breastfeeding
+Women who are pregnant or breastfeeding
+Pregnant and breastfeeding women are excluded from this study
+Patient is pregnant or breastfeeding
+Patient must not be pregnant or breastfeeding
+Females who are breastfeeding or pregnant.
+Patients who are pregnant or breastfeeding
+Participants who are breastfeeding, pregnant or trying to become pregnant
+Breastfeeding, pregnant, or likely to become pregnant during the study
+Pregnant or breastfeeding
+Pregnant or breastfeeding, or planning to become pregnant.
+Patients may not be pregnant or breastfeeding
+For female participants: being pregnant or breastfeeding, or planning to become pregnant, by self-report
+Pregnancy or uninterruptible breastfeeding. Pregnancy is an absolute contraindication under this protocol. Women who are breastfeeding must be willing and able to interrupt breastfeeding during the administration of filgrastim and for two days following the final dose.
+Women must not be breastfeeding
+Patients who are pregnant or breastfeeding or likely to become pregnant
+pregnant or breastfeeding
+not pregnant, breastfeeding, or planning to become pregnant
+Women of childbearing potential who are pregnant or breastfeeding
+Female subject who is pregnant or breastfeeding, or planning to become pregnant within 30 days after ending treatment
+Women who are pregnant or breastfeeding.
+Participants must not be known to be pregnant or breastfeeding
+Women who are pregnant or breastfeeding.
+Women of childbearing potential who are pregnant or breastfeeding
+Pregnant women and women who are breastfeeding are excluded from this study
+Females who are pregnant or breastfeeding.
+Pregnant or breastfeeding women.